Study of a New Generation Botulinum Toxin A2NTX to Treat Spasticity After Stroke

NCT01910363 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Lower Limb Spasticity After Stroke

Interventions

DRUG: A2NTX
DRUG: BOTOX

Sponsor

University of Tokushima

Collaborators

[object Object]